10x Genomics, Inc. (TXG) [Rocket]

In millions, except per share items	Mar-31-23	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21	Jun-30-21
	10-Q	10-Q	10-Q	10-K	10-Q	10-Q
Assets
Current assets:
Cash and cash equivalents	332.3	274.2	312.5	587.4	600.4	622.0
Marketable securities	86.0	225.5	226.8
Restricted cash	2.5	0.5	0.0	1.0	0.0	18.2
Accounts receivable, net	77.9	76.2	76.5	85.3	78.4	59.7
Inventory	82.3	70.6	63.7	60.0	51.1	44.1
Prepaid expenses and other current assets	20.9	19.1	17.8	13.9	14.1	13.3
Total current assets	601.9	666.2	697.3	747.6	744.1	757.2
Property and equipment, net	292.1	223.0	190.2	169.5	142.6	122.3
Restricted cash	5.0	7.1	7.6	7.6	8.6	8.6
Operating lease right-of-use assets	74.7	73.4	75.7	60.9	60.7	54.1
Goodwill	4.5	4.5	4.5	4.5	4.5	4.5
Intangible assets, net	22.9	24.1	24.8	25.4
Other noncurrent assets	12.9	3.2	3.2	3.3	30.1	30.8
Total assets	1,014.0	1,001.6	1,003.3	1,018.8	990.6	977.6

Liabilities and stockholders’ equity
Current liabilities:
Accounts payable	29.3	26.7	19.0	17.4	17.0	16.2
Accrued compensation and related benefits	17.6	23.5	18.3	31.6	27.2	21.1
Accrued expenses and other current liabilities	47.4	53.2	44.1	50.9	46.2	58.5
Deferred revenue	8.5	6.5	5.4	5.3	5.5	5.3
Operating lease liabilities	9.2	8.0	7.6
Total current liabilities	112.0	117.9	94.4	110.4	100.4	113.1
Operating lease liabilities, noncurrent	92.8	91.0	93.5	76.8	75.7	65.9
Other noncurrent liabilities	6.8	9.1	8.6	8.2	8.4	8.1
Total liabilities	211.6	218.1	196.6	201.3	190.4	193.0

Commitments and contingencies (Note 4)
Stockholders’ equity:
Preferred stock
Common stock	0.0	0.0	0.0	0.0	0.0	0.0
Additional paid-in capital	1,883.9	1,757.7	1,714.9	1,680.9	1,644.9	1,612.2
Accumulated deficit	-1,080.1	-970.2	-905.7	-863.3	-844.9	-827.7
Accumulated other comprehensive loss	-1.5	-4.0	-2.4	0.0	0.2	0.1
Total stockholders’ equity	802.4	783.5	806.7	817.6	800.2	784.6
Total liabilities and stockholders’ equity	1,014.0	1,001.6	1,003.3	1,018.8	990.6	977.6